Piper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results
IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best performing S&P 500 stocks to buy now.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 2,639,289 | $1,415,556,262 | -1% | 6.15% |
| 2. | Select Equity Group Robert Joseph Caruso | 573,713 | $307,705,230 | +24% | 1.29% |
| 3. | Generation Investment Management David Blood And Al Gore | 567,322 | $304,277,483 | 1.93% | |
| 4. | AQR Capital Management Cliff Asness | 223,319 | $118,694,968 | +28% | 0.1% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 206,137 | $110,559,519 | +8% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | $99,903.75 | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | $501,875.40 | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | $100,479.51 | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | $178,045.00 | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | $179,580.00 | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $649.85 | 88 | $57,116.68 | 11,287 | 2025-08-12 | Filing | |
| $649.99 | 318 | $206,696.82 | 11,375 | 2025-08-12 | Filing | |
| $656.53 | 1,200 | $787,840.20 | 16,807 | 2025-08-11 | Filing | |
| $651.60 | 5,450 | $3,551,220.00 | 6,156 | 2025-08-08 | Filing | |
| $630.69 | 1,218 | $768,179.32 | 18,007 | 2025-08-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,875,985 | $5,296,885,794 | 0.09% | |
| 2. | 8,373,982 | $4,491,301,365 | 0.09% | |
| 3. | 3,554,424 | $1,906,379,768 | 0.07% | |
| 4. | 2,464,290 | $1,317,874,674 | 0.09% | |
| 5. | 2,032,620 | $1,090,175,411 | 2.96% |
News See All
11 Best Performing S&P 500 Stocks to Buy Now
On August 7, Jonathan Krinsky, BTIG technician, joined CNBC's 'Closing Bell' to discuss his thoughts on the current market standing.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2025 Earnings Conference Call. As a reminder, today's conference is being recorded.
Excellent Execution Drove IDEXX Laboratories (IDXX) Shares Amid Macro Challenges
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Leerink Raises PT on IDEXX Laboratories (IDXX) Stock
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the Best Stocks to Buy According to Brasada Capital Management.
10 Best Stocks to Buy According to Brasada Capital Management
Brasada Capital Management is a leading hedge fund with its headquarters in Houston, Texas. It was established in June 2008 by industry veterans, Mark Edward McMeans and James Gabriel Birdsall.
IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on IDXX.
Should You Consider Adding IDEXX Laboratories (IDXX) to Your Portfolio?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Makes IDEXX Laboratories (IDXX) a Good Investment?
Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.